| Long name: |
GRIM19 Primary Polyclonal Antibody |
| Also known as: |
GRIM19 PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
GRIM19 |
| Specificity: |
This is a highly specific antibody against GRIM19 |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human GRIM19 |
| Gene ID number: |
51079 |
| Tested Applications: |
IF(IHC-P), IHC-P, WB |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity: |
Mouse, Rat, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
Antisense expression of GRIM19 confers a strong resistance against IFN/RA induced death by reducing the intracellular levels of GRIM19 protein, GRIM19 is primarily a nuclear protein whose expression is induced by the IFN/RA combination, Genes associated with Retinoid IFN induced Mortality (GRIM) GRIM19 gene was identified, Overexpression of GRIM19 enhances cell death in response to IFN/RA, These data indicate that GRIM19 is a novel cell death regulatory molecule, A novel gene |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
CGI-39, CGI39 protein, CI-B16, Cell death regulatory protein, Cell death regulatory protein GRIM-19, Complex I-B16, GRIM 19, GRIM-19, GRIM-19, Gene associated with retinoic and N-induced mortality 19 protein, Gene associated with retinoic and interferon-induced mortality 19 protein, Gene associated with retinoic interferon induced mortality 19 protein, NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13, NADH dehydrogenase ubiquinone 1 alpha subcomplex, NADH ubiquinone oxidoreductase B16, Ndufa13, 6, 6, 13, 6 subunit, CDA016 |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
GRIM19 |
| Short name: |
GRIM19 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
GRIM19 (Antibody to) |
| Alternative technique: |
antibodies |
| Identity: |
17194 |
| Gene: |
NDUFA13 |
More about : NDUFA13 |
| Long gene name: |
NADH:ubiquinone oxidoreductase subunit A13 |
| Synonyms gene name: |
13 , NADH dehydrogenase (ubiquinone) 1 alpha subcomplex |
| Synonyms: |
CGI-39 CDA016 GRIM-19 GRIM19 B16, 6 |
| Synonyms name: |
complex I B16, 6 subunit |
| Locus: |
19p13, 11 |
| Discovery year: |
2005-07-20 |
| GenBank acession: |
AF261134 |
| Entrez gene record: |
51079 |
| Pubmed identfication: |
12837546 10924506 15367666 |
| RefSeq identity: |
NM_015965 |
| Classification: |
NADH:ubiquinone oxidoreductase supernumerary subunits |
| Havana BLAST/BLAT: |
OTTHUMG00000162211 |